Fig. 3From: Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studiesLNA-anti-miR-21 caused a significant reduction in B16F10 cell viability compared to the scrambled and control groups (**P < 0.01)Back to article page